The decision tree is shown in Figure I and the probability of surviving the disease can be computed for each branch to determine the preferred treatment.
The management of early microinvasive cervical cancer has been intensely debated for many years. There are advocates of radical therapy if the depth of invasion of a squamous cervical carcinoma is great than 1 mm (Nelson et al., 1975; Averette et al., 1976) while others (Christopherson, 1976; Przybora, 1965; Ruch et al., 1976) The decision tree is shown in Figure I and the probability of surviving the disease can be computed for each branch to determine the preferred treatment.
Estimating the probabilities The survival rates for the various stages of the disease depend on the respective probabilities of spread which, in turn, reflect the probabilities of developing recurrence of the disease. This probability was estimated from a detailed review of 85 papers from the English literature over the past 22 years. These authors analysed their results by depth of invasion from the basement membrane and followed up their patients for at least 5 years. Fifty-five of these papers give probabilistic information on the risk of spread but a further 18 of these were excluded because the depth of invasion was not specifically measured, or invasion to more than 5 mm was included in a single category. This left 34 papers (Table  I) (Hershey et al., 1985; von Neumann & Morgenstern, 1947; Weinstein, 1986) we chose the multiple gamble technique, using certainty equivalence techniques (Hershey et al., 1985) , based on the Von NeumannMorgenstern methodology (von Neumann & Morgenstern, 1947) . Three workers acting independently collected the data.
Sensitivity analysis Sensitivity analysis was performed to assess the influence of infertility and mode of death on the final decision. We considered cases where the subject was indifferent between the two forms of death, where the subject ranked cancer death slightly higher than surgical death (representing the mean in our study) and where the subject rated surgical death twice as undesirable as cancer death. As far as infertility is concerned we included the median score and a range of values defined by the multiple gamble technique. The values ranged from .25 (the lowest score) to 1.00 (indifferent between fertility/ infertility). Although this defines the limits or our sensitivity analysis in clinical practice, treatment must be tailored to each individual patient. (Averette et al., 1976; Christopherson et al., 1976; Ruch et al., 1976; Boutselis et al., 1971; Wilkinson & Komorowski, 1978; Yajima & Noda, 1979; Krishna et al., 1979; Mussey, et al., 1969; Ng & Reagan, 1969; Sedlis et al., 1979; Simon et al., 1986; Taki et al., 1979; Tarkington et al., 1969; Van Nagell et al., 1983; Bohn et al., 1976; Chitale et al., 1977; Creasman et al., 1985; Hasumi et al., 1980; Leman et al., 1976; Margulis et al., 1966;  Thompson, 1968; Roche & Norris, 1975; Ullery et al., 1965; Hsu et al., 1972; Lohe, 1978; Peel et al., in press) and this is slightly better than the survival figure of 30% for patients with stage 1B cervical cancer who are subsequently found to have positive nodes.
An operative mortality of 0.5% (5 per 1,000) was calculated (geometric mean) from the review of 13 recent studies by Shingleton and Orr, 1983 . As published reports may not reflect current achievable results and as results have been improving within the last decade, we have based our calculations both on the above figure and also on a revised probability estimate of surgical mortality of 0.25%.
Determining which treatment optimises survival
The results of decision analysis conducted purely to determine the method of management which maximises the chances of survival are shown in Figures 2 and 3. It is clear Figure 2 Relating the risk of cancer spread to mortality (y axis). The mortality from cone biopsy (i.e. no further treatment) equals the risk of spread (P) (i.e. y = p} and the mortality from radical surgery equals the operative mortality (q) plus the risk of spread (P) times the surgical failure rate (1-r) (i.e. y = q + p (l-r)). Figure 4 Decision tree incorporating subjects utilities; P = -probability of distant spread; q = surgical mortality rate; r = the chance surgery will cure distant spread; U(I) = utility of infertility; U(CD) = utility of cancer death; U(SD) = utility of surgical death. This is because the chance that the lesions have metastasised is less than 0.5% in these cases. However if lymph or blood vascular channels are involved, radical therapy will maximise chances of survival even when the depth of invasion is less than 3 mm, provided that the operative mortality is low (0.25%). This does not apply when the invasion is less than 1 mm if the unit has a higher operative mortality because these lesions have a 0.7% chance of lymph-node spread (only half will be cured by lymphadenectomy and the operative mortality is 0.5%). Threshold analysis can be used to determine which units should offer radical surgery to a woman with stromal lymphatic or vascular involvement. For early lesions (<1 mm invasion) the probability of spread is 0.7%. The mortality associated with radical surgery is the operative mortality (q) plus the probability dying from cancer despite surgery (pr); (i.e. q + 0.35%). When 0.7% = q + 0.35% the survival of such patients is identical irrespective of the therapy chosen. Therefore when the operative mortality rate is 0.35% (q = 0.7%-0.35%) both treatment options are associated with identical survival rates. Below this threshold radical surgery optimises survival but if the mortality exceeds this, cone biopsy (i.e. no further treatment) will achieve the maximum survival.
Utility analysis ignoring infertility Analysis ignoring infertility is appropriate for patients who have completed their family and do not want more children. Sixty per cent of subjects indicated that they would prefer cancer death to surgical death, while 40% had the reverse opinion. On average, subjects indicated that they regarded surgical death to be worse than death from cancer two years later with relative utilities of 0.161 and 0.106 respectively. At an operative mortality of 0.5%, incorporating these utility scores into the decision tree will obviously favour conservative therapy slightly for most patients. If we assume an operative mortality of 0.25%, then surgery is no longer the optimum therapy when the chance of spread is 0.5%. At a chance of spread of 1% or more, however, surgery is still the preferred option regardless of the preferred mode of death (Table III Table In Sensitivity analysis of the expected utility of radical surgery (U(surg)) relative to cone biopsy {U(cone)) for different probabilities of cancer spread (P) and different relative utilities for preferred mode of death U(CD) & U(SD) for a woman who has completed her family (U(I) = 1.00) and assuming q (probability of death from surgery) = 0.25% and the surgical cure rate is 50% Relative utility of cancer and surgical death (U(CD)Iu(sD)) favour conservative therapy (Table IV) . Sensitivity analysis (using a range of utilities) shows that when we use a value of 0.98 (implying indifference between a 1 in 50 risk of death from cancer to avoid the certainty of infertility), conservative therapy becomes the preferred treatment option for microinvasive lesions not involving vessels but invading 3 mm below the basement membrane (Table IV) .
Discussion
Gynaecologists often think that conservative therapy should be superseded by radical surgery when the probability of spread exceeds the operative mortality. Our decision analysis shows that, even from the point of view of maximising survival, this is erroneous because the failure rate of surgery must be taken into account. When depth of invasion is less than 3 mm with no vascular involvement, the risk of spread is so low, that surgery is not warranted. Where invasion exceeds 5 mm or where it exceeds 3 mm with vascular involvement the risk of spread increases exponentially and there must be very few patients for whom conservative therapy is appropriate. Between these two extremes the best treatment depends on the desire to retain fertility.
A large number of observational studies have been directed at determining the probabilities required for this analysis. The risk of spread associated with different histological criteria is central to the analysis. Only a small subset of the large number of papers that have addressed this issue contain aIfthe ratio of the expected utility of surgery to cone biopsy is greater then one surgery is the preferred option. Note:
Based on mean utility scores for cancer death and surgical death (0.161 and 0.106) and probability (q) of surgical death of 0.25%.
information on lymph node pathology and there is no uniformity in reporting depth of invasion or follow-up period. Secondly although the operative mortality of radical surgery has been reported in many studies and quoted as 0.5% the more recent reports tend to show lower mortality figures (approaching 0.25%). As no unit will ever do sufficient radical hysterectomies in a short period of time their precise operative mortality will never be known. Thirdly surgical failure rates of 70% are usually quoted in the presence of lymphatic spread. The references which we have quoted, however, show that the chances of cure are better when spread is less extensive. We have therefore used an estimate that half of patients with spread will be cured by radical therapy usually consisting of extended hysterectomy (Wertheim's) and pelvic lymphadenectomy. Although these are the best data available their accuracy will limit the confidence intervals of any decision analysis. We have also left aside the morbidity of surgery, which may be considerable when ureteric dissection and lymphadenectomy is carried out. Fistulae, for example, occur in nearly 3% of cases (Shingleton & Orr, 1983 ) but surgical complications temporarily reduce life quality and play a trivial part in the final equation dominated by survival and fertility. The final limitation of decision analysis involves our ability to measure the extent to which patients would sacrifice the chances of cure in order to avoid operative death (or vice versa), or to avoid infertility. When obtaining utilities for outcomes the ranking scale is conceptually easier for subjects to use (Gafni & Torrance, 1984) , but this does not produce numerically accurate and definitive answers (Thornton, 1990) . However our findings are confirmed by other reports (McNeil et al., 1981; suggesting that most people prefer delayed death to immediate surgical death. The utility values obtained from the standard gamble method lie close to the range of informed human choice (Torrance, 1986) but there are still several reasons why findings may not accurately reflect subjects' true preferences:-(i) there is a tendency for individuals to exhibit pure risk aversion or a reluctance to gamble per se, (ii) practical behaviour limitations of utility assessment (Bombardier, 1982) and (iii) the difficulty subjects have in interpreting very small probabilities (Torrance, 1986) . It is difficult to eliminate these errors. Furthermore it would be wrong to extrapolate treatment for individuals from population means as the optimum treatment of the disease for the mean population may not be the preferred treatment for that patient. In order to tailor the best treatment to suit each patient, sensitivity analysis was carried out to determine the effect of a range of possible utilities for cancer death, surgical death and infertility on choice of therapy. Table III shows a sensitivity analysis in which we ignore infertility, as one would when treating a patient who had 'completed her family'. When subjects are indifferent between cancer and surgical death, the results are the same as those where we wished simply to maximise chances of survival. However even if patients express a strong wish to avoid either a surgical or cancer death the optimum treatment is unchanged. This shows that our conclusions are very robust to changes in an individual's preference for surgical and cancer death and implies that patients preferences on their method of death are unlikely to change the decision.
The situation is, however, quite different when a range of utility values for infertility are added to the analysis. If we lassume utilities for peri-operative and cancer death of 0.16 and 0.106 respectively (the mean values given by our subjects) and break down the analysis to include different risks of cancer spread these results are very sensitive to changes in the utility of infertility. Thus, when the utility of infertility is 95%, conservative therapy remains the preferred option for all microinvasive lesions even if the chance of spread has increased to 5% (Table IV) . A utility of 0.95 implies that the subject was prepared to lower her chances of survival by 5% to preserve her reproductive function. When this view is felt less strongly but nevertheless keenly, and a patient regards life as 50 times more valuable than fertility, then a utility of 0.98 may be inferred and conservative therapy would then be appropriate for lesions less than 3 mm, but with vascular channel involvement and for lesions penetrating a depth of 3-5 mm with no vascular involvement. In other words the physician must place significant weight on the patient's desire for fertility because it has a major bearing on the choice of treatment.
Although decision analysis has limitations conventional intuitive decisions are also limited by a paucity of hard data. The advantage of decision analysis is that intuitive bias is minimised by breaking down the problem into separate components. Despite the limitations of decision analysis and the difficulty in measuring utility this is the best way to analyse the question 'how should we treat women with early microinvasive cancer of the cervix?'
